Leadership
Dr Jagdale brings extensive leadership experience across API manufacturing, business operations, quality management, supply chain management and regulatory compliance. Throughout his career, he has played a significant role in improving organisational performance through strategic leadership, operational excellence and technology-driven manufacturing practices.
Prior to joining Cohance Lifesciences, he served as President at Emcure Pharmaceuticals from July 2022 to June 2026, where he was responsible for the API business unit’s P&L and key functions, including operations, quality and supply chain management.
Earlier, he served as Chief Operating Officer at Sekhmet Pharmaventures, contributing to its pharmaceutical business operations.
In his new role, Dr Jagdale brings decades of industry expertise to Cohance Lifesciences as the company continues its growth journey.
CXO TechBOT wishes him continued success in his new role.
